You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLTX Sale Disclosure
Reich Kristian · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$944.5K
Reich Kristian Chief Scientific Officer
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
MLTX daily price context
Close on/before transaction
$19.19
Jun 15, 2026
First close after public filing
$19.21
Jun 18, 2026
30-day return after filing
+2.45%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A ordinary shares, par value $0.0001 per share
- Quantity / price
- 50,000 shares @ $18.89
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001213900-26-069753
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.85M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moonlake Immunotherapeutics MLTX | Sale | Jun 17, 2026 | $971.5K |
| Moonlake Immunotherapeutics MLTX | Sale | Jun 16, 2026 | $935K |
| Moonlake Immunotherapeutics MLTX Current | Sale | Jun 15, 2026 | $944.5K |